D

Dr. Agarwal's Health Care Ltd
NSE:AGARWALEYE

Watchlist Manager
Dr. Agarwal's Health Care Ltd
NSE:AGARWALEYE
Watchlist
Price: 486.1 INR -2.72%
Market Cap: 153.7B INR

Dr. Agarwal's Health Care Ltd
Investor Relations

Dr. Agarwal's Health Care Ltd. engages in the operation of eye care hospitals. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2025-02-04. The firm is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. The company provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. The company provides a range of glasses, lenses, contact lenses and frames at its facilities.

Show more
Loading
AGARWALEYE
BSE Sensex 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Oct 31, 2025
AI Summary
Q2 2026

Record Income & Profit: Dr. Agarwal's Health Care crossed INR 1,000 crores in total income for H1 FY '26, with PAT reaching an all-time high of INR 75 crores, up 88.4% year-on-year.

Strong Revenue Growth: H1 FY '26 revenue from operations increased 20.2% year-on-year to INR 986 crores; Q2 revenue rose 19.7% to INR 499 crores.

Margin Expansion: EBITDA margins improved by 100 bps to 28.3% for H1 and by 70 bps to 28.4% for Q2, driven by cost efficiencies and premiumization.

Network Growth: 24 new facilities were added in H1, bringing the total to 258, with a focus on both Tier 1 and smaller cities; rapid expansion is planned for Delhi-NCR.

Surgeries & High-End Procedures: Surgeries grew 14.6% to 137,244 in H1, with strong growth in high-end and robotic cataract surgeries.

Guidance Unchanged: Management expects performance to be in line with previous guidance, despite H1 strength; H2 is typically stronger seasonally.

Key Financials
Total Income (H1 FY '26)
INR 1,007 crores
PAT (H1 FY '26)
INR 75 crores
Revenue from Operations (H1 FY '26)
INR 986 crores
EBITDA (H1 FY '26)
INR 285 crores
EBITDA Margin (H1 FY '26)
28.3%
PAT Margin (H1 FY '26)
7.2%
Total Income (Q2 FY '26)
INR 507 crores
Revenue from Operations (Q2 FY '26)
INR 499 crores
EBITDA (Q2 FY '26)
INR 144 crores
EBITDA Margin (Q2 FY '26)
28.4%
PAT (Q2 FY '26)
INR 36 crores
PAT Margin (Q2 FY '26)
7.2%
Surgeries Performed (H1 FY '26)
137,244
High-End Cataract Surgeries Share
25.8%
Robotic Cataract Surgeries (Femto) (H1)
2,616
Lenticular (SMILE) Surgeries (H1)
2,668
Retinal Surgeries (H1)
6,205
Corneal Transplants (H1)
578
Number of Patients Served (H1)
14.3 lakh
Network Facilities
258
CapEx Guidance (FY '26)
INR 310 crores plus INR 70 crores for flagship
Other Earnings Calls

Management

Dr. Adil Agarwal M.B.B.S, M.S, MBA
CEO & Whole-Time Director
No Bio Available
Dr. Anosh Agarwal M.B.B.S, MBA, MS Ophthal
COO & Wholetime Director
No Bio Available
Mr. Thanikainathan Arumugam
VP of Corporate Affairs, Company Secretary & Compliance Officer
No Bio Available
Mr. Yashwanth Venkat
Chief Financial Officer
No Bio Available
Dr. Ashvin Agarwal
Chief Clinical Officer
No Bio Available
Dr. Ashar Agarwal
Chief Business Officer
No Bio Available
Dr. Vandana Jain M.D.
Chief Strategy Officer
No Bio Available
Mr. Rahul Agarwal
Chief Operating Officer- Hospital Operations
No Bio Available

Contacts

Address
TAMIL NADU
Chennai
1St Floor,Buhari Towers,, No.4,Moores Road, Off Greams Road,, Near Asan Memorial School
Contacts
+914428116233
www.dragarwal.com